Prime award
WESTAT, INC. · Department of Health and Human Services
THE CONTRACTOR SHALL COORDINATE, MAINTAIN AND MANAGE NICHD PARTICIPATING SITES FOR IMPAACT 2041: PHASE I/II STUDY OF THE PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INITIATED IN PREGNANCY IN PEOPLE WITH HEPATITIS C WITH AND WITHOUT HIV.
Current value$1.13M
Obligated to date$0
Months remaining22
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Recompete signal
This award ends in 22 months.
Award record
| Field | Value |
|---|---|
| Recipient | WESTAT, INC. |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541715 |
| PSC | AN11 |
| Place of performance | MD |
| Period | → Jul 31, 2028 |
| Competition | A |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.